Cullen/Frost Bankers’s US Physical Therapy USPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-3
Closed -$204 1393
2026
Q1
$254 Hold
3
﹤0.01% 1349
2025
Q4
$265 Hold
3
﹤0.01% 1385
2025
Q3
$287 Sell
3
-440
-99% -$35.3K ﹤0.01% 1296
2025
Q2
$34.7K Buy
443
+280
+172% +$20.6K ﹤0.01% 819
2025
Q1
$11.8K Buy
+163
New +$13.7K ﹤0.01% 923
2024
Q3
Sell
-8,023
Closed -$741K 1387
2024
Q2
$741K Buy
8,023
+23
+0.3% +$2.33K 0.01% 324
2024
Q1
$903K Hold
8,000
0.01% 308
2023
Q4
$745K Hold
8,000
0.01% 326
2023
Q3
$734K Hold
8,000
0.01% 324
2023
Q2
$971K Buy
+8,000
New +$863K 0.02% 302

Other funds holding USPH

Cullen/Frost Bankers's USPH Position: Q2 2026 in Review

Cullen/Frost Bankers sold out of US Physical Therapy (USPH) in Q2 2026, closing a stake of 3 shares — an estimated $204 sold.

Cullen/Frost Bankers first reported a position in USPH in Q2 2023 and held it in 10 quarters. The position peaked at $971K in Q2 2023. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.

  • Cullen/Frost Bankers reported no remaining US Physical Therapy position as of Q2 2026 after selling out during the quarter.
  • Cullen/Frost Bankers sold 3 US Physical Therapy shares in Q2 2026, an estimated $204.
  • Cullen/Frost Bankers first reported a position in US Physical Therapy in Q2 2023 and held it in 10 quarters.
  • Cullen/Frost Bankers's US Physical Therapy position peaked at $971K in Q2 2023.
  • 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.